The 20 Best Desmoplastic Small Round Cell Tumor Doctors Near Me in San Francisco, CA

Lejla Delic is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Delic is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy. Dr. Delic is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology.

Dr. Eric Nakakura is a cancer surgeon who specializes in tumors of the liver, pancreas, bile ducts and gastrointestinal tract. He also treats soft tissue sarcomas, including tumors of the retroperitoneum (a space in the abdominal cavity), trunk and extremities. At the UCSF Helen Diller Family Comprehensive Cancer Center, he helps manage complex gastrointestinal tract cancers, soft tissue sarcomas and gastrointestinal neuroendocrine tumors, including carcinoid and islet cell tumors. In his research, Nakakura studies endocrine differentiation in gastrointestinal tumors. Nakakura earned his medical degree at Stanford University School of Medicine. He earned a doctorate in cellular and molecular medicine at Johns Hopkins University. He completed a residency in general surgery at Johns Hopkins Medicine and received advanced training in surgery at the John Radcliffe Hospital in Oxford, England. At Johns Hopkins, he completed a fellowship in surgical oncology with an emphasis on pancreatic, biliary and gastrointestinal surgery. Dr. Nakakura is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nakakura is board certified in American Board Of Surgery, General Surgery. Dr. Nakakura is currently accepting new patients.

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Gauri Kelekar is an Oncologist practicing medicine in San Francisco, California. She has been practicing medicine for over 18 years. Dr. Kelekar is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Hemochromatosis, Familial Colorectal Cancer, and Urothelial Cancer. Dr. Kelekar is board certified in Medical Oncology - Internal Medicine Hematology. Dr. Kelekar is currently accepting new patients.

Thierry Jahan is an Oncologist practicing medicine in San Francisco, California. Dr. Jahan is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, and Lung Cancer.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Quock is currently accepting new patients.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Shen is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Vulvar Cancer, Endometrial Stromal Sarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Shen is board certified in OB & Gyn (Sub: Gynecologic Oncology) and Obstetrics & Gynecology. Dr. Shen is currently accepting new patients.

Lee-may Chen is an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Salpingo-Oophorectomy, and Oophorectomy.

Donald Abrams is an Oncologist practicing medicine in San Francisco, California. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

Dr. Edwin Alexander Alvarez is a gynecologic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. He focuses on the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other cancers of the female reproductive system. He performs traditional, complicated and minimally invasive gynecologic surgeries. UCSF recruited Alvarez to serve as director of clinical trials for the Division of Gynecologic Oncology. He is involved with NRG Oncology, a cooperative research group for cancer clinical trials sponsored by the National Cancer Institute. Before coming to UCSF, he directed chemotherapy services for gynecologic cancers at the University of California, Davis. In addition to caring for patients, Alvarez has a strong commitment to teaching medical students, residents and fellows. Dr. Alvarez is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Hernia Surgery. Dr. Alvarez is board certified in American Board Of Obstetrics And Gynecology, Gynecologic Oncology and American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Alvarez is currently accepting new patients.

Caroline Behler is a Hematologist practicing medicine in San Francisco, California. Dr. Behler is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 72 other conditions, according to our data. Her clinical expertise encompasses Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Bone Marrow Aspiration, and Gamma Knife Radiosurgery.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Dr. Lucas W. Thornblade is a surgical oncologist who cares for patients with digestive system cancers, including colon, rectal, liver, pancreas, gallbladder, bile duct and stomach cancers. He also cares for patients with melanoma or sarcomas, (cancerous tumors that form in bones or soft tissues). In his research, Thornblade focuses on improving cancer care delivery at safety net hospitals (those that serve a large number of uninsured and Medicaid patients). He also studies disparities in outcomes for patients with stomach and metastatic colon and rectal cancer. Thornblade earned his medical degree at the Boston University Chobanian & Avedisian School of Medicine. He completed a residency in general surgery at the University of Washington and a fellowship in complex general surgical oncology at City of Hope. He also has a master of public health degree from the University of Washington. He is a fellow of the American College of Surgeons. Dr. Thornblade is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Diverticular Disease, Gastrointestinal Perforation, Esophageal Perforation, Pancreaticoduodenectomy, and Colostomy. Dr. Thornblade is board certified in American Board Of Surgery, Complex General Surgical Oncology and American Board Of Surgery, Surgery. Dr. Thornblade is currently accepting new patients.

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer. As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment. Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology. Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Dr. Aggarwal is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Melanoma of the Eye, and Muscle Invasive Bladder Cancer. Dr. Aggarwal is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Aggarwal is currently accepting new patients.

Dr. Katherine Fuh is a gynecologic oncologist who specializes in diagnosing and managing cancers of the female reproductive system, including advanced ovarian and uterine cancers. Her expertise includes chemotherapy, targeted therapy and immunotherapy. Fuh earned her medical degree at Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Stanford University, where she also earned a doctorate in cancer biology. She completed a fellowship in gynecologic oncology through a joint program of UCSF and Stanford Medicine. As a physician-scientist, Fuh studies how to improve outcomes for patients with ovarian or uterine cancer. She is nationally known for her use of molecular biomarkers (measurable biological indicators of disease) to guide and personalize therapy. Her laboratory focuses on identifying biomarkers associated with treatment resistance in patients with ovarian cancer and developing targeted therapies to overcome the resistance. She has been involved in numerous clinical trials (studies that use human volunteers to evaluate promising treatments) and is the principal investigator for one of the first clinical trials of a new drug for patients with treatment-resistant metastatic ovarian cancer. She is also the principal investigator on multiple research projects that received grants from various federal funders and foundations. She has published many scientific papers on gynecologic cancers, and her research has advanced how doctors approach treating these diseases. Prior to joining UCSF, Fuh was a faculty member at Washington University School of Medicine in St. Louis. In addition to directing translational and basic research there, she was an integral member of the division of gynecologic cancer and the cancer center. Dr. Fuh is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hysterectomy. Dr. Fuh is board certified in American Board Of OB/Gynecologic Oncology, Gynecologic Oncology and American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Fuh is currently accepting new patients.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Ko is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ko is currently accepting new patients.

Stefanie Ueda is an Oncologist practicing medicine in San Francisco, California. Dr. Ueda is rated as an Advanced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Bladder Reconstruction, and Hysterectomy.

Robert Weber is a Hematologist and an Oncologist practicing medicine in Daly City, California. Dr. Weber is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Weber is board certified in Internal Medicine (Sub: Medical Oncology), Internal Medicine (Sub: Hematology), and Internal Medicine. Dr. Weber is currently accepting new patients.

Brian Schulte is a Hematologist practicing medicine in San Francisco, California. Dr. Schulte is rated as an Experienced provider by MediFind in the treatment of Desmoplastic Small Round Cell Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, Liposarcoma, and Fibrosarcoma.